NEW DELHI: India is considering a significant escalation in its use of water from the Indus river system, a move that could drastically reduce the water supply to Pakistan. This development comes ...

“It's time to correct the errors of previous governments concerning the Indus Water Treaty, which favours Pakistan over Indian farmers,” stated Dharmendra Mallik, spokesperson for BKU (Non ...

Alongside the plans to expand Ranbir canal, Delhi is also considering projects that would likely reduce the flow of water into Pakistan, according to two government documents seen by Reuters and ...

Acadia Pharmaceuticals (NASDAQ:ACAD) soared 28% after a court ruling in patent suit regarding its drug Nuplazid, which is used to treat Parkinson's disease. The court ruled that Aurobindo Pharma ...

BioMarin Pharmaceutical has agreed to acquire Inozyme Pharma for $4 ashare, or about $270 million in cash. The companies said Friday that their tie-up would strengthen BioMarin's enzyme therapies ...

India has no plans to hold talks with Pakistani authorities on the Indus Waters Treaty, which will remain suspended, two people familiar with the matter said. India has no plans to hold talks with ...

He also emphasized that India will maintain the freeze on the Indus water treaty until Pakistan halts terrorism. Foreign minister S Jaishankar, speaking of Operation Sindoor and cessation of ...

Pakistan has reportedly written a letter to India, urging it to reconsider the decision to put the Indus Waters Treaty into abeyance. Pakistan's Ministry of Water Resources has reportedly written ...

Recursion Pharmaceuticals RXRX shares have plunged 21.6% so far in May. This considerable decline in the stock was observed after the company reported weaker-than-expected first-quarter 2025 ...

Pakistan has said it is willing to restart talks with India regarding the Indus Water Treaty (IWT) which India has kept in abeyance following the Pahalgam terror ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

GSK GSK2.07%increase; green up pointing triangle will acquire a liver-disease treatment from Boston Pharmaceuticals for up to $2 billion as it seeks to boost its pipeline of new drugs. The British ...